Strategic partnerships MBC BioLabs has a track record of collaborating with big players and corporate partners (AbbVie, Eisai Innovation, PerkinElmer, Meiji Seika Kaisha) and is expanding through multi-site operations. This creates an opportunity to position your offerings as enterprise-grade support for their incubator network and portfolio startups, with a focus on scaling collaborations, joint programs, or sponsored accelerator initiatives.

Seed to scale With revenue in the mid-range and a proven impact of enabling 500+ startups and 176 clinical trials, MBC BioLabs is a mature accelerator with ongoing demand for equipment, facility expansion, and operational support. Target them with high-value lab infrastructure, consumables partnerships, and scalable services tailored to growing biotech ventures.

Multi-site footprint Five locations including San Francisco and San Carlos provide geographic diversification and proximity to diverse biotech ecosystems. This presents an upsell opportunity for regional facilities management, remote instrumentation support, cross-site supply chains, and coordinated programs across sites for startups expanding nationally.

Tech-enabled MBC BioLabs employs a modern tech stack for analytics and operations and has demonstrated engagement with venture-friendly programs. Propose data-driven lab services, LIMS integrations, analytics tooling, and automation partnerships that enhance startup outcomes and operational efficiency within their ecosystem.

Funding and visibility Active involvement with prize programs and high-profile corporate partners signals strong fundraising activity and market interest. Approach them with premium sponsorship packages, accelerator fund-raising collaborations, and co-branded events to boost startup visibility and deal flow within their community.